Other than having the same George Soros hack go after them there is none.
Travis County Grand Jury Indictments of by Tom Delay, innocent of all charges after 11 years, Kay Hagen, thrown out and now Rick Perry for trying to fire the drunken driving (3 times the legal limit for drunk driving) abusive Rosemary Lehmberg, DA of Travis County who is supposed to be an officer of the court, So he gets indicted for doing his job. Black is White and White is Black!
Sentiment: Strong Buy
Yes, Rick Perry is best governor in U.S. I Live in NY state. With Andrew Cuomo as governor we have worst economy; no jobs, no fracking, no growth. Just High taxes. The "Progressive" sure know how to ruin a beautiful state with bountiful resources.
Sentiment: Strong Buy
Down today because Zacks dropped them from a # 1 rank to a # 5 rank. Seems like their ranking is very fickle. I thought the Conference Call was positive in many respects. The MLC is advancing and is being rolled out in a careful manner. The service side is receiving high rankings. Order growth is good. Levine is executing as he has promised.
So what if earning loss was greater than Zacks estimate. I just means that Zacks earning estimate was wrong and they don't trust their estimates and they are now unloading,. If they don't trust themselves why should anyone else trust them? Up until now I had them as a hold. Now I rate them a buy.
So do I. Revenue seems to be about half systems and half service. So system order growth translates into same amount of service order growth, so order growth gets doubled.
Thanks for sharing your knowledge with the board. It is always nice to find knowledgeable posters. I will look forward to reading yours.
The tax is not insignificant. A local Medical Device Company here in Central New York cut 10 percent of their work force 275 jobs in the past year because of the Medical Device tax. Anytime the government passes laws that affect an industry the law an it's effects are valid to discuss in an industry message board. If the PPACA is so wonderful why is "the medical-device and health-insurance industries are doing everything within their power to repeal these "harmful" taxes." (source: PHARMA & HEALTHCARE 7/19/201). When the IRS already takes up to 39% on profits and now wants over 2 percent of revenues off-the-top, the taxes become draconian, especially for small medical device startup companies. It dries up risk capital and stifles innovation which is responsible for most of the advances in better, and less expensive, health care.
ISRG results are good news for innovation, computer assisted surgery and medical device companies. Innovation is the best way to improve medical outcomes and decrease long term health care cost. It shows the insanity of the Medical Device Tax and another nail in the coffin of the misnamed Patient Protection and Affordable Care Act.
Yellen prints money destroys value through inflation. Biotech's discover better and less expensive ways to treat illnesses which creates real value. She is a dunce.
There is a book "Dying to Get to Oklahoma" by Ash Mackinnon who's wife had to go from Australia to Oklahoma to get CK treatments. The book was written after she died in 2007 as an effort to get the Australian Heath Service (I don't know it's official title) to get a CK in Australia. After all these years it is good to see they got one. Maybe things really are looking up. The book is still available on Amazon.
I would not worry...
ASTRO Says Few Cancers Qualify for Proton Therapy
Published: Jun 4, 2014
By Charles Bankhead, Staff Writer, MedPage Today
Evidence to support reimbursement for proton-beam therapy remains limited to several relatively uncommon cancers, although some patients enrolled in clinical trials also should receive coverage consideration.
Note that American Society for Radiation Oncology officials found sufficient evidence to support reimbursement for ocular tumors, lesions at or near the base of the skull, primary or metastatic tumors of the spine, hepatocellular carcinoma treated with hypofractionated regimens, primary or benign tumors in children, and patients with genetic syndromes that increase the importance of minimizing total radiation volume.'
TRXC will be on market sooner (6-18 months) and a little less expensive. More designed for gall bladder removal and places where cauterizing sufficient to close surgery, e.g. cholecystectomies, etc. TITXF will be more sophisticated will be able to do more repair type surgery. There will be market for both and I own both.